Global Pharmacovigilance Insights, QA & Regulatory Updates

News

Global Regulatory & Industry Updates US FDA, MHRA & EMA

12 February, 2024

Medical Device CGMP: Quality System Regulations Guide

Blog / Videos

Technical Pharmacovigilance & QA Guidance

13 February, 2026

FDA Pharmacovigilance Inspection Readiness Checklist | Expert Audit Preparation for 21 CFR 314 & 600

11 February, 2026

Signal Management Consulting for FDA and EMA: Early Signal Identification Best Practices

11 February, 2026

Early-Stage Biotech Pharmacovigilance Consulting for FDA and EMA Compliance

11 February, 2026

FDA and EMA Inspection Readiness Consulting: Top Services for GVP Audit and Compliance Checklist

11 February, 2026

DSUR in Pharmacovigilance: FDA, EMA and ICH E2F Development Safety Update Report Guide

9 February, 2026

Pharmacovigilance Outsourcing Services: How and when for Global Pharma, Biotech, and CROs

Case Studies

Strategic Pharmacovigilance Case Studies

9 February, 2026

Pharmacovigilance Outsourcing Services: How and when for Global Pharma, Biotech, and CROs

23 January, 2026

Strategic ICSR & Literature Surveillance Consulting for Global MAHs (US, EU, UK)

12 February, 2024

PV Inspection Readiness Case Study | Global Pharmacovigilance